| Control | Epinephrine | Levosimendan |
P
|
---|
Weight(g) | 289 ± 10 | 287 ± 6 | 288 ± 6 | 0.940 |
HR(beats/min) | 287 ± 10 | 285 ± 10 | 285 ± 6 | 0.913 |
LvdevP(mm Hg) | 140 ± 10 | 139 ± 10 | 137 ± 6 | 0.768 |
RPP(mm Hg·beats/min) | 40,183 ± 2279 | 39,461 ± 2073 | 39,101 ± 2092 | 0.599 |
+dP/dtmax (mm Hg/s) | 4152 ± 358 | 4189 ± 214 | 4141 ± 248 | 0.704 |
CF(ml/min) | 20.5 ± 0.9 | 21.3 ± 0.9 | 21.4 ± 0.7 | 0.089 |
Ts(s) | 33 ± 6 | 36 ± 11 | 34 ± 8 | 0.188 |
- Values are given as the mean ± standard deviation, n = 8 in each group. Baseline values for major variables showed no significant differences among the 3 groups. Control: lipid only; Epinephrine: combined epinephrine+ lipid; Levosimendan: combined levosimendan + lipid. HR: heart rate; LVdevP: left ventricular developed pressure; RPP: rate-pressure product; +dP/dtmax: maximum change rate of left ventricular pressure increase and decrease; CF: coronary flow; Tasystole: the time from initiation to asystole